신경 다양성 평가 및 스크리닝 플랫폼 시장 예측(-2032년) : 컴포넌트별, 연령층별, 도입 형태별, 용도별, 최종사용자별, 지역별

According to Stratistics MRC, the Global Neurodiversity Assessment & Screening Platforms Market is accounted for $350.0 million in 2025 and is expected to reach $788.36 million by 2032 growing at a CAGR of 12.3% during the forecast period. Neurodiversity Assessment & Screening Platforms are technology-based solutions that help detect and understand diverse neurological conditions, such as autism spectrum disorders, ADHD, and learning differences. They combine digital questionnaires, data analysis, and intelligent algorithms to deliver accurate screenings and tailored feedback. These platforms make assessments more accessible by allowing online evaluations and consistent reporting for schools, workplaces, and healthcare providers. By supporting early identification and continuous monitoring, they enable better intervention strategies and personalized support plans. Overall, such platforms play a key role in promoting inclusion, reducing stigma, and creating supportive environments that recognize and value cognitive diversity in academic, clinical, and professional settings.

According to the National Library of Medicine (2021 study), the unemployment rate among autistic adults is around 40%, which is significantly higher than the general population.

Market Dynamics:

Driver:

Growing awareness of neurodiversity

Increasing understanding of neurodiversity among institutions and society is strongly fueling market growth. Educational bodies, healthcare providers, and employers now view neurological differences as part of human diversity, creating demand for systematic screening solutions. Awareness campaigns and supportive policies highlight the importance of early identification and tailored assistance. As stigma declines, more individuals and organizations are willing to adopt structured digital assessments. This cultural shift drives the need for accessible platforms that can evaluate cognitive differences, guide interventions, and support inclusion, ultimately expanding the use of neurodiversity assessment and screening technologies across multiple sectors.

Restraint:

High cost of implementation and maintenance

Elevated costs associated with deploying and maintaining neurodiversity assessment platforms restrict market growth. These solutions rely on sophisticated technologies that demand substantial upfront and ongoing financial resources. Organizations must also allocate budgets for training, upgrades, cybersecurity, and platform integration. Smaller institutions often struggle to justify such investments, even when the long-term value is recognized. As a result, cost sensitivity acts as a barrier, particularly in price-conscious markets, reducing adoption rates and limiting the widespread use of digital neurodiversity screening solutions.

Opportunity:

Expansion into corporate HR and talent management

Rising adoption of inclusive hiring practices presents significant growth potential for the market. Companies are looking for reliable tools to understand neurodiverse talent and design supportive workplace strategies. Neurodiversity screening platforms can be embedded into HR processes to enable fair recruitment, customized onboarding, and employee development. By aligning individual strengths with job roles, organizations can improve engagement and outcomes. As corporate focus on diversity and inclusion intensifies, these platforms gain opportunities to expand beyond healthcare and education into enterprise-level talent management solutions.

Threat:

Intensifying competition and market fragmentation

Rising competitive pressure represents a major threat to market stability. The increasing number of solution providers offering similar screening functionalities intensifies rivalry and fragments demand. Aggressive pricing strategies and limited differentiation can weaken revenue potential. Established technology firms entering the market further heighten competition due to their scale and brand strength. As competition grows, smaller or specialized platform providers may struggle to maintain market share, making consolidation or exit more likely and limiting long-term growth opportunities.

Covid-19 Impact:

COVID-19 strongly influenced the neurodiversity assessment and screening platforms market by driving rapid adoption of virtual assessment technologies. Restrictions on physical interactions reduced the availability of face-to-face evaluations, pushing schools, clinics, and organizations to use online screening tools. Growth in telehealth and remote education supported wider acceptance of digital platforms. At the same time, disparities in internet access and concerns over data security became more visible. These factors shaped innovation priorities, encouraging more accessible, secure, and flexible neurodiversity screening solutions for post-pandemic environments.

The software platforms segment is expected to be the largest during the forecast period

The software platforms segment is expected to account for the largest market share during the forecast period as they form the core infrastructure for neurodiversity screening and evaluation. By combining assessment tools, intelligent analysis, and user-friendly interfaces, these platforms enable efficient and repeatable screenings across multiple sectors. Their flexibility supports online delivery, personalized assessments, and seamless integration with existing systems. Organizations favor software platforms because they simplify large-scale implementation, improve consistency, and reduce dependence on manual processes. This functional versatility and scalability make software platforms the most widely adopted segment in neurodiversity assessment and screening solutions.

The adults (18+ years) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the adults (18+ years) segment is predicted to witness the highest growth rate. Growing awareness that conditions such as ADHD, autism, and dyslexia persist into adulthood has encouraged more individuals to pursue evaluations. Organizations and universities increasingly use digital platforms to identify support needs and improve inclusion strategies. Adults prefer flexible, private, and online screening options that fit busy lifestyles. This shift toward adult-focused assessments, combined with workplace inclusion initiatives and rising self-advocacy, is accelerating adoption and positioning the adult segment as the highest-growth category in the market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by well-developed technology ecosystems and strong recognition of neurodiverse needs. The region benefits from early integration of digital solutions across healthcare, education, and employment sectors. Organizations actively use screening platforms to support inclusion, compliance, and early intervention initiatives. Availability of skilled professionals, favorable regulatory environments, and high adoption of remote assessment tools enhance market penetration. These combined factors position North America as the leading region in terms of overall market share.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving awareness and expanding digital infrastructure. Educational institutions and healthcare organizations are turning to online screening solutions to meet growing demand efficiently. Supportive government programs, increased access to mobile technologies, and a rising emphasis on inclusive learning contribute to adoption. With a large and diverse population seeking accessible assessment options, the region is experiencing rapid uptake of digital neurodiversity platforms, making Asia Pacific the highest-growth market segment globally.

Key players in the market

Some of the key players in Neurodiversity Assessment & Screening Platforms Market include Lumosity, MoCA Cognition, HappyNeuron, Cognistat, BrainFx, Dystech, CogniFit, Cambridge Cognition, Creyos Health, CNS Vital Signs, Do-IT Profiler, GL Assessment, Qbtech, Gabify and Aignosis.

Key Developments:

In June 2025, Qbtech announces the formation of its Houston-based clinical research and strategic partnership teams, along with new staff appointments and promotions at the company's US headquarters. The employee expansions bolster the company's continued growth in the region, enhancing its capabilities and market presence as it continues to develop and enhance its software solutions.

In October 2016, CogniFit introduces CogniFit for Education, a new web-portal for teachers to assess, train, and monitor cognitive skills involved in the learning processes. The CogniFit for Education platform starts with students completing a scientifically validated and gamified cognitive assessment.

Components Covered:

• Software Platforms
• Services

Age Groups Covered:

• Children (0-12 years)
• Adolescents (13-17 years)
• Adults (18+ years)

Deployment Modes Covered:

• Cloud-Based
• On-Premise

Applications Covered:

• Dyslexia Screening
• ADHD Screening
• Autism Spectrum Disorder (ASD) Screening
• Dyspraxia Screening

End Users Covered:

• Educational Institutions
• Healthcare Providers
• Corporate Organizations
• Research Institutes
• Government Agencies

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Neurodiversity Assessment & Screening Platforms Market, By Component

• 5.1 Introduction
• 5.2 Software Platforms
• 5.3 Services

6 Global Neurodiversity Assessment & Screening Platforms Market, By Age Group

• 6.1 Introduction
• 6.2 Children (0-12 years)
• 6.3 Adolescents (13-17 years)
• 6.4 Adults (18+ years)

7 Global Neurodiversity Assessment & Screening Platforms Market, By Deployment Mode

• 7.1 Introduction
• 7.2 Cloud-Based
• 7.3 On-Premise

8 Global Neurodiversity Assessment & Screening Platforms Market, By Application

• 8.1 Introduction
• 8.2 Dyslexia Screening
• 8.3 ADHD Screening
• 8.4 Autism Spectrum Disorder (ASD) Screening
• 8.5 Dyspraxia Screening

9 Global Neurodiversity Assessment & Screening Platforms Market, By End User

• 9.1 Introduction
• 9.2 Educational Institutions
• 9.3 Healthcare Providers
• 9.4 Corporate Organizations
• 9.5 Research Institutes
• 9.6 Government Agencies

10 Global Neurodiversity Assessment & Screening Platforms Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Lumosity
• 12.2 MoCA Cognition
• 12.3 HappyNeuron
• 12.4 Cognistat
• 12.5 BrainFx
• 12.6 Dystech
• 12.7 CogniFit
• 12.8 Cambridge Cognition
• 12.9 Creyos Health
• 12.10 CNS Vital Signs
• 12.11 Do-IT Profiler
• 12.12 GL Assessment
• 12.13 Qbtech
• 12.14 Gabify
• 12.15 Aignosis